Table of Contents
ISRN Oncology
Volume 2014, Article ID 931858, 7 pages
http://dx.doi.org/10.1155/2014/931858
Review Article

Idelalisib for the Treatment of Chronic Lymphocytic Leukemia

1Department of Internal Medicine, Saint Joseph Hospital, 2900 N. Lake Shore, Chicago, IL 60657, USA
2Dow University of Health Sciences, Karachi 74200, Pakistan
3Department of Internal Medicine, Presence Resurrection Medical Center, 7435 West Talcott Avenue Chicago, IL 60631, USA

Received 19 February 2014; Accepted 12 March 2014; Published 1 April 2014

Academic Editors: L. Jia and H. Zhang

Copyright © 2014 Maliha Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Maliha Khan, Areeba Saif, Steven Sandler, and Aibek E. Mirrakhimov, “Idelalisib for the Treatment of Chronic Lymphocytic Leukemia,” ISRN Oncology, vol. 2014, Article ID 931858, 7 pages, 2014. https://doi.org/10.1155/2014/931858.